Showing 3004 results
-
Story /More than 125 million people worldwide live with psoriasis, a chronic autoimmune disease that causes red, scaly patches to appear on the skin.
-
Story / -
Story /Boston University developed a methodology to evaluate the impact of Novartis Access in Kenya. Peter C. Rockers tells us about the ongoing study.
-
In The News /In an editorial for Pharmaphorum, Dr. Kiliko, Head Customer Services at Mission for Essential Drugs and Supplies (MEDS), showcases how Pharma companies play a vital role in improving access-to-…
-
In The News /Novartis Chairman Joerg Reinhardt says the successful fight against infectious diseases in poor countries provides valuable lessons for the emerging crisis of chronic diseases.
-
In The News /Humanosphere highlights the work Novartis Access is doing to find a social enterprise solution to help patients in lower-income countries get access to medicines for chronic diseases.
-
In The News /Chronic diseases like high blood pressure and diabetes impact more than just wealthy nations. Through the Novartis Foundation and Novartis Access, we’re working to address the rising threat of…
-
In The News /In Forbes commentary, Novartis CEO says industry should focus on outcomes for patients and healthcare systems.
-
In The News /An editorial by Anthony Gitau, Head of Novartis Access in Kenya
-
In The News /How two years in a Novartis lab changed Johnny Castillo's life